Trial intelligence / Profile preview

PK/PD of insulin aspart delivered by needle-free jet injection versus conventional pen

2009-015398-11Phase 4Completed

Sponsor
Radboud University Medical Center
Start
Sep 2009
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

Phase 4 trial of insulin aspart in diabetes mellitus type 1 (T1D) (2 arms), sponsored by Radboud University Medical Center. Primary endpoint: Pharmacodynamic profile of insulin. Started Sep 2009; status: completed.

02

Drugs

insulin aspart
03

Conditions

diabetes mellitus type 1 (T1D)

Beyond the preview

Go deeper on 2009-015398-11.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2009-015398-11.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call